Cargando…
Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses
BACKGROUND: The PHArmacogenetic study of Statins in the Elderly at risk (PHASE) is a genome wide association study in the PROspective Study of Pravastatin in the Elderly at risk for vascular disease (PROSPER) that investigates the genetic variation responsible for the individual variation in drug re...
Autores principales: | Trompet, Stella, de Craen, Anton JM, Postmus, Iris, Ford, Ian, Sattar, Naveed, Caslake, Muriel, Stott, David J, Buckley, Brendan M, Sacks, Frank, Devlin, James J, Slagboom, P Eline, Westendorp, Rudi GJ, Jukema, J Wouter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207930/ https://www.ncbi.nlm.nih.gov/pubmed/21977987 http://dx.doi.org/10.1186/1471-2350-12-131 |
Ejemplares similares
-
C-Reactive Protein and Genetic Variants and Cognitive Decline in Old Age: The PROSPER Study
por: Mooijaart, Simon P., et al.
Publicado: (2011) -
Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Lloyd, Suzanne M., et al.
Publicado: (2013) -
Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Poortvliet, Rosalinde K. E., et al.
Publicado: (2012) -
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Freeman, Dilys J, et al.
Publicado: (2011) -
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies
por: Trompet, S., et al.
Publicado: (2015)